The stock price of uniQure N.V (NASDAQ: QURE) has jumped by 4.41 compared to previous close of 17.22. Despite this, the company has seen a gain of 3.16% in its stock price over the last five trading days. fool.com reported 2024-12-15 that Shares of the international gene therapy developer uniQure (QURE 2.26%) have been soaring. Investors are responding to positive news regarding the Food and Drug Administration (FDA) and the company’s Huntington’s disease candidate.
Is It Worth Investing in uniQure N.V (NASDAQ: QURE) Right Now?
Moreover, the 36-month beta value for QURE is 0.48. Analysts have varying opinions on the stock, with 9 analysts rating it as a “buy,” 3 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for QURE is 42.40M and currently, short sellers hold a 10.14% of that float. On December 31, 2024, QURE’s average trading volume was 2.06M shares.
QURE’s Market Performance
The stock of uniQure N.V (QURE) has seen a 3.16% increase in the past week, with a 201.17% rise in the past month, and a 289.18% gain in the past quarter. The volatility ratio for the week is 6.69%, and the volatility levels for the past 30 days are at 11.18% for QURE. The simple moving average for the past 20 days is 27.19% for QURE’s stock, with a 171.74% simple moving average for the past 200 days.
Analysts’ Opinion of QURE
Raymond James, on the other hand, stated in their research note that they expect to see QURE reach a price target of $20. The rating they have provided for QURE stocks is “Outperform” according to the report published on October 10th, 2024.
Goldman gave a rating of “Neutral” to QURE, setting the target price at $8 in the report published on February 29th of the current year.
QURE Trading at 89.25% from the 50-Day Moving Average
After a stumble in the market that brought QURE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.77% of loss for the given period.
Volatility was left at 11.18%, however, over the last 30 days, the volatility rate increased by 6.69%, as shares surge +153.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +181.93% upper at present.
During the last 5 trading sessions, QURE rose by +3.84%, which changed the moving average for the period of 200-days by +250.10% in comparison to the 20-day moving average, which settled at $14.14. In addition, uniQure N.V saw 165.58% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at QURE starting from Kapusta Matthew C, who sale 100,000 shares at the price of $15.03 back on Dec 10 ’24. After this action, Kapusta Matthew C now owns 597,915 shares of uniQure N.V, valued at $1,503,000 using the latest closing price.
Kapusta Matthew C, the CEO, Managing Director of uniQure N.V, sale 3,418 shares at $7.63 during a trade that took place back on Dec 09 ’24, which means that Kapusta Matthew C is holding 597,915 shares at $26,079 based on the most recent closing price.
Stock Fundamentals for QURE
Current profitability levels for the company are sitting at:
- -7.16 for the present operating margin
- -0.11 for the gross margin
The net margin for uniQure N.V stands at -8.38. The total capital return value is set at -0.36. Equity return is now at value -147.56, with -31.57 for asset returns.
Based on uniQure N.V (QURE), the company’s capital structure generated 0.5 points at debt to capital in total, while cash flow to debt ratio is standing at -3.23. The debt to equity ratio resting at 0.99. The interest coverage ratio of the stock is -3.17.
Currently, EBITDA for the company is -253.1 million with net debt to EBITDA at 1.17. When we switch over and look at the enterprise to sales, we see a ratio of 24.55. The receivables turnover for the company is 5.37for trailing twelve months and the total asset turnover is 0.04. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.51.
Conclusion
To wrap up, the performance of uniQure N.V (QURE) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
